Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Developing a bacteriophage platform technology for use in animal health has taken Polish company Proteon Pharmaceuticals a decade to master. Chief operating officer Mathew Tebeau talks to Animal Pharm analyst Malcolm Flanagan about the firm's past and future.
Managing human behaviour, enhancing international cooperation and conducting more scientific research have been pinpointed as crucial elements to eradicate African Swine fever (ASF) from the EU.
The EU is to move its reference laboratory for foot and mouth disease (FMD) after Brexit, switching its responsibilities from the UK to a consortium based in France and Belgium.
The Japanese Ministry of Agriculture, Forestry and Fisheries (JMAFF) has approved products from Virbac, IDEXX Laboratories and three local companies.
Zoetis has secured approval for two biologics in Canada, according to the latest update from the Canadian Food Inspection Agency (CFIA).
US agricultural investment firm TechAccel has underlined the need for more venture capital investment in animal health – music to the ears of many start-ups in the industry.
Recent independent trial results have backed Aquila Diagnostic Systems, as the Canadian company works towards its debut product approval.
Earlier this month, a joint webinar from Animal Pharm and Kisaco Research canvassed the opinions of three key industry experts regarding the state of innovation in animal health. Animal Pharm editor Joseph Harvey spoke to Nesya Goris of ViroVet, Theo Kanellos from Zoetis and George Gunn from Stonehaven Consulting. Below is a transcript of the webinar.
Canadian healthcare data tools company Ehave is expanding its business into animal health.
The UK has boosted its aquaculture health capability with the opening of a new fish disease research center.
Two US firms have combined their expertise to create a new state-of-the-art genomic profiler for Angus seedstock cattle.
Leading US animal health diagnostics specialist IDEXX Laboratories said its livestock, poultry and dairy (LPD) segment third-quarter revenues have been squeezed in China by new import trends and restrictive regulations.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.